Search
for
Sort by
Research 61–90 of 1000+
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Using artificial intelligence to analyze publicly available social media posts to understand patient perspectives toward specific treatments of alopecia areata
- 0250 Systemic therapy associates with a lower incidence of male infertility among psoriasis patients
- Platelet-Rich Plasma In Androgenetic Alopecia:An Evidence-Based Clinical And Biological Review
- Application of Thulium 1927-nm Laser for Androgenic Alopecia Treatment in Indonesian Patients.
- Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Integrated edge information and pathway topology for drug-disease associations
- Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Diagnosis and treatment of isolated autosomal recessive woolly hair/hypotrichosis
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Mesenchymal stem cell-derived exosomes for the treatment of skin and subcutaneous tissue diseases: current evidence from clinical trials
- Milagros enterprise Group S.A.S.: high-quality products in hair health international business plan
- The PDGF/PDGFR pathway as a drug target
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Comparative Analysis of Labeling and Claim Substantiation Requirements for Herbal Hair Products across Different Regulatory Jurisdictions
- Enhancing dermatology clinical trials: optimizing sites and strategies for success in India
- Interventions for morphea
- Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
- Research Trends and Hotspots in Female Pattern Hair Loss: A Bibliometric Study
- AAPS and PSRC 2016 Abstract Supplement
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis
- Celiac Disease: Beyond Diet and Food Awareness
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions